San Diego, CA, August 13, 2025 — Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the appointment of Sam Whiting, M.D., Ph.D., as Chief Medical Officer. Dr.